Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001754429-24-000006
Filing Date
2024-08-20
Accepted
2024-08-20 17:59:22
Documents
1
Period of Report
2024-08-19

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4819
  Complete submission text file 0001754429-24-000006.txt   6608
Mailing Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494
Business Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494 617-494-1199
BIOXYTRAN, INC (Issuer) CIK: 0001445815 (see all company filings)

EIN.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1905 S AUDUBON CT SPOKANE WA 99224
Business Address
Sheikh Michael (Reporting) CIK: 0001640636 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35027 | Film No.: 241226545